Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer.

The androgen-signaling pathway plays an important role in the development and hormonal progression of prostate cancer to the castrate-resistant stage (also called androgen-independent or hormone refractory). The Wnt pathway and beta-catenin contribute to prostate biology and pathology. Here application of Affymetrix GeneChip analysis revealed the genomic similarity of the LNCaP hollow fiber model to clinical samples and identified genes with differential expression during hormonal progression. The fiber model samples clustered according to the expression profile of androgen-regulated genes to provide genomic evidence for the reactivation of the AR signaling pathway in castrate-resistant prostate cancer. Pathway-based characterization of gene expression identified activation of the Wnt pathway. Together with the increased expression of AR and beta-catenin, there was increased nuclear colocalization and interaction of endogenous AR and beta-catenin in castrate-resistant prostate cancer from castrated mice. Surprisingly, no interaction or colocalization of AR and beta-catenin could be detected in xenografts from noncastrated mice. These studies provide the first in vivo evidence to support aberrant activation of the AR through the Wnt/beta-catenin signaling pathway during progression of prostate cancer to the terminal castrate-resistant stage.

[1]  Colleen C Nelson,et al.  Interaction of nuclear receptors with the Wnt/beta-catenin/Tcf signaling axis: Wnt you like to know? , 2005, Endocrine reviews.

[2]  R. Vessella,et al.  Molecular determinants of resistance to antiandrogen therapy , 2004, Nature Medicine.

[3]  J. D. Miller,et al.  Prostate-specific Antigen Expression Is Regulated by an Upstream Enhancer (*) , 1996, The Journal of Biological Chemistry.

[4]  A. Potti,et al.  Up-regulation of Wnt-1 and beta-catenin production in patients with advanced metastatic prostate carcinoma: potential pathogenetic and prognostic implications. , 2004, Cancer.

[5]  R. Kemler,et al.  The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. , 1989, The EMBO journal.

[6]  E. Gelmann,et al.  β-Catenin Mutations in Human Prostate Cancer , 1998 .

[7]  O. Jänne,et al.  Cyclin D1 binds the androgen receptor and regulates hormone-dependent signaling in a p300/CBP-associated factor (P/CAF)-dependent manner. , 2001, Molecular endocrinology.

[8]  A. Sparks,et al.  Identification of c-MYC as a target of the APC pathway. , 1998, Science.

[9]  Yajun Yi,et al.  Molecular Alterations in Primary Prostate Cancer after Androgen Ablation Therapy , 2005, Clinical Cancer Research.

[10]  M. Sadar,et al.  Characterization of a new in vivo hollow fiber model for the study of progression of prostate cancer to androgen independence. , 2002, Molecular cancer therapeutics.

[11]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Zijie Sun,et al.  Roles and regulation of Wnt signaling and beta-catenin in prostate cancer. , 2006, Cancer letters.

[13]  Jeong Hoon Kim,et al.  Synergistic effects of coactivators GRIP1 and beta-catenin on gene activation: cross-talk between androgen receptor and Wnt signaling pathways. , 2004, The Journal of biological chemistry.

[14]  T. Stamey,et al.  Prostate-Specific Antigen as a Serum Marker for Adenocarcinoma of the Prostate , 1987 .

[15]  E. Wilson,et al.  Liganded androgen receptor interaction with beta-catenin: nuclear co-localization and modulation of transcriptional activity in neuronal cells. , 2002, The Journal of biological chemistry.

[16]  W. Isaacs,et al.  The cadherin cell-cell adhesion pathway in prostate cancer progression. , 1997, British journal of urology.

[17]  L. Sapinoso,et al.  Dysregulated expression of androgen-responsive and nonresponsive genes in the androgen-independent prostate cancer xenograft model, CWR22-R , 2000, Nature Genetics.

[18]  B. Zbar,et al.  Oncogenic Mutants of RON and MET Receptor Tyrosine Kinases Cause Activation of the β-Catenin Pathway , 2001, Molecular and Cellular Biology.

[19]  D. Tindall,et al.  Mechanisms of androgen-refractory prostate cancer. , 2004, The New England journal of medicine.

[20]  R. Nusse,et al.  Wnt3a Growth Factor Induces Androgen Receptor-Mediated Transcription and Enhances Cell Growth in Human Prostate Cancer Cells , 2004, Cancer Research.

[21]  W. Isaacs,et al.  Expression of the cellular adhesion molecule E-cadherin is reduced or absent in high-grade prostate cancer. , 1992, Cancer research.

[22]  W. Isaacs,et al.  In vitro evidence for complex modes of nuclear β-catenin signaling during prostate growth and tumorigenesis , 2002, Oncogene.

[23]  K. Knudsen,et al.  Specificity of cyclin D1 for androgen receptor regulation. , 2003, Cancer research.

[24]  A. Passaniti,et al.  Expression of E‐cadherin reduces Bcl‐2 expression and increases sensitivity to etoposide‐induced apoptosis , 2000, International journal of cancer.

[25]  Jörg Stappert,et al.  β‐catenin is a target for the ubiquitin–proteasome pathway , 1997 .

[26]  K. Knudsen,et al.  Cyclin D1: Mechanism and Consequence of Androgen Receptor Co-repressor Activity* , 2002, The Journal of Biological Chemistry.

[27]  E. Gelmann,et al.  β-Catenin Binds to the Activation Function 2 Region of the Androgen Receptor and Modulates the Effects of the N-Terminal Domain and TIF2 on Ligand-Dependent Transcription , 2003, Molecular and Cellular Biology.

[28]  Hans Clevers,et al.  XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos , 1996, Cell.

[29]  R. Grosschedl,et al.  Regulation of LEF-1/TCF transcription factors by Wnt and other signals. , 1999, Current opinion in cell biology.

[30]  D. Tindall,et al.  Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. , 2002, Cancer research.

[31]  P. Riegman,et al.  The promoter of the prostate-specific antigen gene contains a functional androgen responsive element. , 1991, Molecular endocrinology.

[32]  Chawnshang Chang,et al.  Suppression of Androgen Receptor-mediated Transactivation and Cell Growth by the Glycogen Synthase Kinase 3β in Prostate Cells* , 2004, Journal of Biological Chemistry.

[33]  S. Brewster,et al.  Wnt signalling and prostate cancer , 2005, Prostate Cancer and Prostatic Diseases.

[34]  Paul S Rennie,et al.  Functional localization and competition between the androgen receptor and T-cell factor for nuclear β-catenin: a means for inhibition of the Tcf signaling axis , 2003, Oncogene.

[35]  P. Morin,et al.  β‐catenin signaling and cancer , 1999 .

[36]  Frank McCormick,et al.  β-Catenin regulates expression of cyclin D1 in colon carcinoma cells , 1999, Nature.

[37]  Zijie Sun,et al.  Phosphatidylinositol 3-Kinase/Akt Stimulates Androgen Pathway through GSK3β Inhibition and Nuclear β-Catenin Accumulation* , 2002, The Journal of Biological Chemistry.

[38]  M. Gleave,et al.  Prostate and bone fibroblasts induce human prostate cancer growth in vivo: implications for bidirectional tumor-stromal cell interaction in prostate carcinoma growth and metastasis. , 1992, The Journal of urology.

[39]  D. Longo,et al.  Linking β-Catenin to Androgen-signaling Pathway* , 2002, The Journal of Biological Chemistry.

[40]  A. Sabichi,et al.  Glycogen Synthase Kinase-3β Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity* , 2004, Journal of Biological Chemistry.

[41]  Spyro Mousses,et al.  Failure of hormone therapy in prostate cancer involves systematic restoration of androgen responsive genes and activation of rapamycin sensitive signaling , 2001, Oncogene.

[42]  P. Polakis.  Wnt signaling and cancer. , 2000, Genes & development.

[43]  S. Balk,et al.  Recruitment of β-Catenin by Wild-Type or Mutant Androgen Receptors Correlates with Ligand-Stimulated Growth of Prostate Cancer Cells , 2004 .

[44]  N. Heisterkamp,et al.  p120 Catenin-Associated Fer and Fyn Tyrosine Kinases Regulate β-Catenin Tyr-142 Phosphorylation and β-Catenin-α-Catenin Interaction , 2003, Molecular and Cellular Biology.

[45]  W. Bremner,et al.  Advances in male contraception. , 2008, Endocrine reviews.

[46]  J. Trapman,et al.  Two Androgen Response Regions Cooperate in Steroid Hormone Regulated Activity of the Prostate-specific Antigen Promoter (*) , 1996, The Journal of Biological Chemistry.

[47]  M. Rubin,et al.  β-Catenin-related Anomalies in Apoptosis-resistant and Hormone-refractory Prostate Cancer Cells , 2003 .

[48]  E. Gelmann,et al.  Beta-catenin affects androgen receptor transcriptional activity and ligand specificity. , 2000, Cancer research.

[49]  G. Wang,et al.  Amino‐terminus domain of the androgen receptor as a molecular target to prevent the hormonal progression of prostate cancer , 2006, Journal of cellular biochemistry.

[50]  Desok Kim,et al.  Androgen receptor expression in androgen-independent prostate cancer is associated with increased expression of androgen-regulated genes. , 1998, Cancer research.

[51]  G. Wang,et al.  Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells , 2006, Oncogene.